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OBJECTIVE: To analyze the blood pressure patterns in normoalbuminuric IDDM
patients with glomerular hyperfiltration.
PATIENTS AND METHODS: A controlled cross-sectional study of 38
normotensive normoalbuminuric (urinary albumin excretion rate <20 µg/min)
IDDM patients (18 hyperfiltering [glomerular filtration rate > 134 ml × min-1×
1.73m-2] and 20 normofiltering) and 20 normal individuals matched for age,
sex, and body mass index was performed. The 24-h ambulatory blood pressure
was monitored using an auscultatory technique; the glomerular filtration rate
was measured by 51Cr-labeled EDTA method; extracellular volume by the
distribution volume of 51Cr-labeled EDTA; and 24-h urinary albumin excretion
rate by radioimmunoassay.
RESULTS: Mean nocturnal diastolic blood pressure was higher in hyperfiltering
IDDM patients (70.4 ± 7.8 mmHg), when compared with the control group
(65.1 ± 5.3 mmHg, P = 0.04). Diastolic blood pressure night:day ratio was
higher in hyperfiltering IDDM patients (92.0 ± 8.6%), when compared with
normofiltering IDDM patients (85.9 ± 4.8%) and control subjects (87.0 ± 6.8%,
P = 0.02). In IDDM patients, the glomerular filtration rate significantly correlated
with the diastolic blood pressure night:day ratio (r = 0.5, P = 0.002), extracellular
volume (r = 0.4, P = 0.002), and HbA1 (r = 0.3, P = 0.03). In stepwise multiple
regression analysis, factors associated with glomerular filtration rate were
diastolic blood pressure night:day ratio, extracellular volume, and HbA1 (adjusted
r2 = 0.27, P = 0.003).
CONCLUSIONS: Glomerular hyperfiltration is associated with higher nocturnal
diastolic blood pressure and with a blunted nocturnal decrease in diastolic
blood pressure levels in normotensive and normoalbuminuric IDDM patients.
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A hiperfiltração glomerular está associada a alterações de pressão
sangüínea em pacientes DMDI normotensivos
OBJETIVO: Analisar os padrões de pressão sangüínea em pacientes
normoalbuminúricos DMDI com hiperfiltração glomerular.
PACIENTES E MÉTODOS: Foi feito um estudo controlado em cortes
transversais com 38 pacientes normoalbuminúricos normotensivos (taxa de
excreção urinária de albumina>20 µg/min) DMDI (hiperfiltração em 18 [taxa
de filtração glomerular>134 ml x  min-1 x 1,73m-2] e normofiltração em 20), e de
20 indivíduos normais agrupados por idade, sexo, e índice de massa corporal.
A pressão sangüínea ambulatorial foi monitorada em 24 h pelo método
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auscultatório; a taxa de filtração glomerular foi medida através do método
51Cr-EDTA; o volume extracelular, através do volume de distribuição do 51Cr-
EDTA; e a taxa excreção urinária de albumina em 24 h, por radioimunoensaio.
RESULTADOS: A média da pressão sangüinea diastólica noturna foi mais
alta em pacientes DMDI com hiperfiltração (70,4 + 7,8 mmHg), quando
comparada à do grupo controle (65,1 + 5,3 mmHg, P=0,04). A relação
diurna:noturna da pressão sangüínea diastólica foi mais alta em pacientes
DMDI com hiperfiltração (92,0 + 8,6%) quando comparada a mesma relação
dos pacientes DMDI com normofiltração (85,9 + 4,8%) e controles (87,0 +
6,8%, P=0,02). Os pacientes DMDI apresentaram uma taxa de filtração
glomerular significativamente correlacionada com a relação diurna:noturna
de pressão diastólica (r=0,5, P=0,002), com o volume extracelular (r=0,4,
P=0,002), e com HbA1 (r=0,3, P=0,03). Na análise de regressão múltipla
escalonada, os fatores associados com a taxa de filtração glomerular foram:
relação diurna:noturna de pressão sangüinea diastólica, volume extracelular,
e HbA1 (ajustado r
2=0,27, P=0,003).
CONCLUSÕES: Hiperfiltração glomerular está associada à pressão
sangüínea diastólica noturna elevada e a uma diminuição noturna abrupta
dos níveis de pressão sangüínea diastólica em pacientes normotensivos e
em pacientes DMDI normoalbuminúricos.
Unitermos: DMDI; taxa de excreção urinária de albumina; pressão sangüínea.
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Introduction
An increased glomerular filtration rate
(GFR) has been considered a risk factor for the
development of diabetic nephropathy in IDDM
patients (1). However, the role of glomerular
hyperfiltration remains controversial. In a 10-year
prospective study, baseline albumin excretion rate
and blood pressure (BP) were the main risk
factors for renal outcome. Baseline GFR was an
independent determinant of final blood pressure
(2).
Increased levels of arterial BP were
detected in normoalbuminuric IDDM patients who
progress to microalbuminuria (3). Alterations in
ambulatory BP (ABP) parameters were observed
in normoalbuminuric IDDM patients (4-6) and
have been associated with diabetes duration (6)
and with higher urinary albumin excretion rate
(UAER) levels (4), although within the normal
range. Abnormalities of circadian BP variation
were also described in microalbuminuric IDDM
patients (7-9). However, GFR was not taken into
account in these studies.
It can be hypothesized  that if there was an
association of glomerular hyperfiltration and
abnormalities of BP homeostasis, it would be
possible to identify IDDM patients with a higher
risk for the development of diabetic nephropathy.
Therefore, the aim of the study was to analyze
BP patterns in normoalbuminuric normotensive
IDDM patients with glomerular hyperfiltration.
Patients and methods
This study followed a controlled cross-
sectional design. Thirty-eight IDDM patients
followed between 1986 and 1989 at the diabetes
outpatient clinic at Hospital de Clínicas de Porto
Alegre (a tertiary care center) were studied. The
GFR and UAER of these patients are being
measured at ~1-year intervals (10). Informed
consent was obtained from each patient, and the
protocol was approved by the ethics committee.
The definition of IDDM was based on World
Health Organization criteria (11), i.e., onset of
diabetes age < 40 years, a previous episode of
ketoacidosis or documented ketonuria, and
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obligatory use of insulin for life maintenance. The
inclusion criteria were as follows: diabetes
duration for > 1 year; >18 years of age; 24-h
UAER <20 µg/min on at least two different
occasions; office ambulatory BP <140/90 mmHg;
absence of coronary heart disease (normal
maximal exercise electrocardiogram) or other
cardiac disease; absence of renal disease
(normal urinary sediment and negative culture);
and absence of autonomic neuropathy (more
than one abnormal result out of five
cardiovascular autonomic reflex tests) (12). None
of the patients were obese (BMI < 30 kg/m2).
Patients were conventionally treated with one or
two daily subcutaneous insulin injections, except
for one patient who took four injections per day.
Office auscultatory BP was measured twice in a
sitting position after a 10-min rest, with a standard
12.5-cm cuff mercury sphygmomanometer
(phases I-V), and the mean BP value was used.
These patients were classified as hyperfiltering
(n=18) and as normofillering (n = 20) according
to the upper limit of normal GFR range previously
established in normal volunteers at our unit (mean
+ 2 SD = 134.0 ml × min-1 ×1.73 m-2) (13). The
condition of hyperfiltration and normofiltration was
confirmed at least three times before the
experiment, and 20 healthy individuals matched
to the patients for age, sex distribution, BMI,
ethnicity, smoking habit, and use of oral
contraceptive formed the control group.
The same researcher installed the 24-h
ABP monitors in the morning. Patients and control
subjects were asked to continue their daily
activities and to complete a 24-h report on values
of home glucose monitoring (before breakfast,




, and if hypoglycemia
was suspected), number of cigarettes smoked
and other exceptional activities (for instance,
extra physical activity or arguing).
The 24-h ABP was measured with a
lightweight battery-operated ambulatory BP
monitoring device (Pressurometer IV, Del Mar
Avionics, Irvine, CA) using an auscultatory
technique. Before sampling, the pressurometer
programmer, a computer used with the
Pressurometer IV program was used to test and
program the monitor. The programmer is also
used together with the test kit to calibrate the
pressurometer against a mercury manometer to
ensure proper transducer placement and
sensitivity. After sampling, the programmer can
be interfaced with a printer to generate a
comprehensive tabular report showing sampling
times and unedited systolic, diastolic, and heart
rate readings. The monitor was programmed to
take measurements every 10 min from 7:00 A.M.
to 11:00 P.M. and every 15 min from 11:00 P.M.
to 7:00 A.M.. The mean diurnal and nocturnal
BP and heart rate were calculated based on each
Table1. Clinical characteristics of IDDM patients and control groupa
aData are n or mean ± SD (range). All P values are nonsignificant.
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34.8 ± 7.8 (22-51)
9/11
1/19





8.4 ± 4.7 (1-17)




32.7 ± 6.0 (22-47)
10/10
2/18










32.1 ± 6.4 (22-40)
10/8
4/14





6.5 ± 4.4 (1-15)











Familial history of hypertension
Oral contraceptive use
Duration of diabetes (years)
Insulin dose (U × kg-1× day -1)
Background retinopathy
Peripheral neuropathy
Hyperfiltering               Normofiltering          Control
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patient’s self-recorded time for going to bed and
rising in the morning.
The GFR was measured using the 51Cr-
labeled EDTA single injection technique
(coefficient of variation [CV] = 11.2%) and
calculated as a monoexponential function of the
plasma disappearance curve according to
Chantler and Barrat (14). Extracellular volume
(ECV) was estimated as the distribution volume
of 51Cr-labeled EDTA (15). UAER was determined
by radioimunoassay (DPC, Los Angeles, CA;
inter-and intra-assay CV = 2.3 and 2.8%,
respectively) in 24-h sterile specimens. Glucose
was measured by the glucose-oxidase method,
HbA1  by a microchromatographic system
(Labtest; normal range 5.3-8.0%), and
fructosamine by a colorimetric method (NBT
reduction, Labtest; normal range: 1.87-2.87
mmol/l), creatinine by Jaffe’s reaction, urinary
urea by a kinetic reaction, urinary sodium by flame
photometry and cholesterol, HDL, and
triglycerides by a colorimetric method.
Statistical analysis
The three groups were compared by
analysis of variance (ANOVA) followed by the
Student-Newman-Keuls (SNK) test. Student’s t
test or Mann-Whitney’s ranksum test was used
to compare normofiltering and hyperfiltering
IDDM patients. Differences between groups for
discrete variables were evaluated by the Fisher’s
exact test and the χ2 test. Pearson’s correlation
test was used for the correlation between GFR
and systolic and diastolic BP night:day (N:D)
ratios. To examine a nonlinear relation between
the GFR and diastolic BP N:D ratio, a statistical
method to determine the breakpoint of two lines
(a changepoint model) was used (16). Stepwise
multiple linear regression analysis were carried
Table 2. Laboratory features of IDDM patientsa
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Urinary sodium excretion (mEq/h)
24-h urinary urea (g)
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4.4 ± 1.0 (3.0-6.6)
1.4 ± 0.5 (0.7-2.5)




















4.4 ± 0.7 (3.3-6.1)
1.3 ± 0.3 (0.8-2.0)




















Hyperfiltering                         Normofiltering                   P value
aData are mean ± SD (range). For UAER data are expressed as median range. Home glucose monitoring represents
the mean of four measurement per day.
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24-h heart rate (beats/min)
Diurnal sBP (mmHg)
Diurnal dBP (mmHg)
Diurnal heart rate (beats/min)
Nocturnal sBP (mmHg)
Nocturnal dBP (mmHg)
Nocturnal heart rate (beats/min)
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Hyperfiltering                     Normofiltering                       Control
out to determine the effects of different variables
on GFR variation. Data were expressed as means
± SD, except for the UAER analysis, for which
median and range were used. P < 0.05 was
considered significant.
Results
The clinical characteristics of IDDM patients
and control subjects are shown in Table 1. No
difference was observed when comparing age,
sex, ethnicity, BMI, smoking habits, number of
valid 24-h ABP readings, family history of
hypertension, and the number of tests performed
on leisure days (day-off) or working days (day-
in) among the three groups (P > 0.05).
When clinical and laboratory features were
compared between hyper- and normofiltering
patients (Table 2), the only differences observed
were lower levels of triglycerides and serum
creatinine and higher ECV levels in hyperfiltering
There was no difference between normofiltering
and control patients (ANOVA; P = 0.02; SNK <
0.05). Individual values of diastolic BP N:D ratios
are shown in Figure 1. These results did not
change when the control subject with the lower
value of diastolic BP N:D ratio was excluded from
the analyses. The systolic BP N:D ratio was also
higher in hyperfiltering patients (88.4 ± 8.1%) as
compared with normofiltering patients (81.5 ±
10.5%) and with the control group (83.6 ± 6.8%),
but it did not reach the conventional statistical
significance level (ANOVA, P = 0.055). The
proportion of nondippers, defined in this study
as the subjects in whom the reduction of diastolic
BP was < 10% from day to night, was higher in
hyperfiltering patients (10/18) when compared
with normofiltering patients (3/20) and the control
group (6/20) (χ2, P = 0.02), without any difference
between normofiltering patients and the control
group.
In the group of diabetic patients,
patients. By definition, GFR was different for the
two groups.
ABP and heart rate values are described
in Table 3. The nocturnal diastolic BP was
significantly higher in hyperfiltering patients when
compared with the control group (ANOVA, P =
0.04; SNK < 0.005). Differences in the diurnal
variation of ABP were addressed by calculating
the N:D ratio. The diastolic BP N:D ratio was
higher in hyperfiltering patients (92.0 ± 8.6%),
when compared with normofiltering patients (85.9
± 4.8%) and the control group (87.0 ± 6.8%).
correlations (Pearson’s tests) were calculated for
GFR and diastolic BP N:D ratio (Figure 2A; r =
0.5, P = 0.002), ECV (Figure 2B; r = 0.4, P =
0.002), HbA
1 
(r = 0.3, P = 0.03), diabetes duration
(r = -0.05, P = 0.4), log AER (r = 0.1, P = 0.2),
and urinary sodium (r = 0.09, P = 0.3). Variables
with a P value <0.10 were entered in a stepwise
multiple linear regression analysis with GFR as
the dependent variable. The results were as
follows: diastolic BP N:D ratio (adjusted r2 = 0.19,
F = 9.4, P = 0.004), diastolic BP N:D ratio + ECV
+ HbA1 (adjusted r2 = 0.27, F = 57, P = 0.003). A
aData are means ± SD. sBP, systolic blood pressure; dBP, diastolic blood pressure.
bP = 0.02, hyperfiltering vs. control.
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Figure 2. Correlations (Pearson’s tests) between GFR and
diastolic BP N:D ratios (A) and ECV (B) in IDDM patients.
l, normofiltering patients; ¡, hyperfiltering patients.
Figure 1. Individual night:day ratio for systolic (A) and
diastolic (B) blood pressure in IDDM patients and healthy
control subjects. HYPER, hyperfiltering patients (n = 18);
NORMO, normofiltering patients (n = 20); CONTROL,
control subjects (n = 20). Horizontal lines indicate the
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statistical analysis to determine the breakpoint
in the correlation of GFR and diastolic BP N:D
ratio disclosed that a broken line fitted significantly
(F = 57.1) better than a straight line. The
breakpoint was 140 ml × min-1 × 1.73 m-2, and
GFR values under this level were not correlated
with diastolic BP N:D ratio.
Conclusions
In this study, IDDM patients with glomerular
hyperfiltration presented higher levels of
nocturnal diastolic BP. GFR was associated with
a blunted decrease in diastolic BP, with increased
ECV and HbA1.The diastolic BP N:D ratio was
the main factor contributing for GFR variation.
There is probably a threshold in GFR values
above which there is an association with BP
abnormalities. The breakpoint analysis disclosed
that only GFR values > 140 ml × min-1 × 1.73 m-
2 presented a significant correlation with the
diastolic BP N:D ratio. This GFR value is closer
to the upper limit of GFR previously established
in our unit, of 134 ml × min-1 × 1.73 m-2 (13).
It is well known that GFR is influenced by
the degree of metabolic control in IDDM (17) and
NIDDM patients (18). In the present study, HbA1
variation accounted only for about 3% of the GFR
variation. The relationship between GFR and
ECV has already been reported by us (19) and
others (20). Theoretically, the observed
expansion of ECV could explain the abnormalities
of the BP pattern in hyperfiltering IDDM patients.
However, the blood volume was not different in a
similar group of normofiltering and hyperfiltering
IDDM patients (19). It could be speculated that
during the night, in a recumbent position, there
could be a redistribution of ECV leading to a
transient increase in blood volume.
Higher levels of nocturnal BP in
normotensive normoalbuminuric IDDM patients
were also reported by other authors (5,6). In the
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study by Gilbert et al. (5), there is no mention as
to whether ABP monitoring was performed on
working or nonworking  days. Another study (6)
evaluated only male patients, and the authors
did not mention smoking habits, the number of
tests performed on working days, and the criteria
used to define the night period. The authors
compared patients with a diabetes duration of
12 years with patients with a diabetes duration
of 2.4 years.
Diabetes duration has been reported to
influence ABP patients in normoalbuminuric
IDDM patients (6, 21). In those studies, the night
heart rate was higher in patients with a longer
duration of diabetes, possibly indicating the
presence of vagal neuropathy. Neither of these
studies had performed proper autonomic function
tests. It has already been shown that autonomic
dysfunction is associated with blunted decrease
of nocturnal diastolic BP in normoalbuminuric
IDDM patients (22). In our study, the patients did
not present abnormalities in autonomic
cardiovascular tests or a higher nocturnal heart
rate. However, we could not exclude an early
autonomic dysfunction if more sensitive methods
had been applied. The effect of the longer
duration of diabetes could, in fact, represent the
presence of autonomic neuropathy.
Other authors have not found any
significant difference in the BP N:D ratio between
normoalbuminuric IDDM patients and healthy
control subjects (24,24). In the study by Hansen
et al. (23), ABP monitoring was performed more
often on nonworking days (71% in IDDM patients
and 75% in control subjects) than in the present
study (24% in IDDM patients and 29% in the
control group; P < 0.01 for both comparisons).
The duration of diabetes was also longer (18
years) than in our subjects (7.5 years). In another
study (24), the number of patients and healthy
individuals was small (12 in each group), fixed
night periods were used to calculate the nocturnal
BP mean (11:00 P.M. to 7:00 A.M
.
), and all the
patients were admitted to the hospital for the night
measurements. The authors did not mention
whether normal individuals were also admitted.
The GFR was not measured in any of the
studies mentioned above.
The association between GFR and an
altered circadian BP rhythm could identify a
subset of IDDM patients more susceptible to
future development of diabetic nephropathy.
Prospective studies of this particular group of
patients should be conducted. In conclusion, in
normotensive and normoalbuminuric IDDM
patients, glomerular hyperfiltration is associated
with a higher nocturnal diastolic BP and with a
blunted nocturnal decrease in diastolic BP levels.
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